Yubo International Biotech Ltd Income Statement
YBGJ|15 years of annual SEC 10-K data (FY2010-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Yubo International Biotech Ltd reported $12,353 in revenue and $1M in net loss for FY2025. Revenue has declined at a 68.4% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.4K | $3.5K | $604.7K | $104.3K | $1.2M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $4.2K | $822 | $185.5K | $51.6K | $423.7K | $114.3K | - | - | - | - | - | - | - | - | - |
| Gross Profit | $8.2K | $2.6K | $419.2K | $52.7K | $820.6K | $1.2M | - | - | - | - | - | - | - | - | - |
| SG&A Expense | - | - | - | - | - | $29.0K | $48.0K | $58.0K | $58.0K | $149.0K | $63.0K | $58.0K | $55.0K | $47.0K | $80.0K |
| Operating Income | -$1.2M | -$1.8M | -$1.2M | -$1.2M | -$1.5M | -$711.8K | -$48.0K | -$58.0K | -$58.0K | -$149.0K | -$63.0K | -$58.0K | -$55.0K | -$47.0K | -$80.0K |
| Interest Expense | - | - | -$377 | - | $427 | $105.0K | $100.0K | $86.0K | $86.0K | $75.0K | $67.0K | $58.0K | $51.0K | $37.0K | $30.0K |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | - | - | - | - |
| Net Income | -$1.1M | -$1.8M | -$1.2M | -$1.2M | -$1.5M | -$711.8K | -$148.0K | -$148.0K | -$144.0K | -$224.0K | -$130.0K | -$116.0K | -$106.0K | -$84.0K | -$110.0K |
| EPS (Diluted) | -$0.01 | -$0.10 | -$0.10 | - | - | -$0.13 | -$0.12 | -$0.12 | -$0.12 | -$0.19 | -$0.11 | -$0.10 | -$0.09 | -$0.09 | -$0.09 |
| Shares Outstanding | 139.6M | 12.0M | 12.0M | - | - | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M | - | - |
| Gross Margin | 66.1% | 76.3% | 69.3% | 50.5% | 66.0% | - | - | - | - | - | - | - | - | - | - |
| Operating Margin | -9614.6% | -51006.3% | -197.6% | -1155.7% | -124.0% | - | - | - | - | - | - | - | - | - | - |
| Profit Margin | -8736.7% | -51171.4% | -197.6% | -1155.5% | -124.0% | - | - | - | - | - | - | - | - | - | - |